Written By: Jon Suyko, PharmD, BCPS UCHealth Highlands Ranch
Venetoclax (Venclexta) therapy requires particular parameters be closely followed to ensure optimal patient outcomes. This PQI will review appropriate risk stratification, dosing, and dispensing procedures. These risk stratifications create special challenges for the dispensing of venetoclax. Some medium-risk and all high-risk patients may require hospital admission during titration; communication between the oncology pharmacist, nurse, lab technicians, hematologist, and the patient will ensure the recommended administration guidelines and lab monitoring are followed to ensure patient safety and best outcomes.